Feasibility Study of the Use of Ultra-low Dose Iodinated Contrast Agent for Endovascular Procedures in Patients With Chronic Limb-threatening Ischemia and Renal Impairment
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
The purpose of this protocol is to study the safety and feasibility of using ultra-low dose iodinated contrast agent for infrainguinal endovascular revascularization procedures in patients with chronic limb-threatening lower limb ischemia (CLTI) and impaired renal function, in the new angiography suite of our department.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• CLTI
• Prescheduled infrainguinal revascularization procedure
• Renal disease stage 2-4 (eGFR \<60ml/minute/1.73m2)
• Adequate pre- and post-procedural hydration protocol
Locations
Other Locations
Greece
ATTIKON University General Hospital, , 1st Rimini St,
RECRUITING
Chaïdári
Contact Information
Primary
Stavros C Spiliopoulos, MD, PhD
stavspiliop@med.uoa.gr
+302105831810
Backup
Vasiliki Zygouri, MD
vasilikizig1510@gmail.com
+3-2105831844
Time Frame
Start Date: 2024-09-01
Estimated Completion Date: 2025-12
Participants
Target number of participants: 15
Treatments
Study cohort
Patients with renal disease stages 2-4, scheduled to undergo infrainguinal endovascular procedures due to CLTI, using ultra-low dose of iodine contrast media.
Related Therapeutic Areas
Sponsors
Leads: Attikon Hospital